Linc AB (STO:LINC)

Market Cap	4.42B +13.1%
Revenue (ttm)	437.99M +103.8%
Net Income	419.45M +71.7%
EPS	n/a
Shares Out	57.91M
PE Ratio	10.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	82,327
Average Volume	38,029
Open	77.10
Previous Close	77.10
Day's Range	76.20 - 77.90
52-Week Range	58.90 - 83.60
Beta	0.71
RSI	61.09
Earnings Date	Jul 17, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC